PDB Short entry for 2O7N HEADER CELL ADHESION 11-DEC-06 2O7N TITLE CD11A (LFA1) I-DOMAIN COMPLEXED WITH 7A-[(4-CYANOPHENYL)METHYL]-6-(3, TITLE 2 5-DICHLOROPHENYL)-5-OXO-2,3,5,7A-TETRAHYDRO-1H-PYRROLO[1,2-A]PYRROLE- TITLE 3 7-CARBONITRILE COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTEGRIN ALPHA-L; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: VWFA DOMAIN, RESIDUES 154-332; COMPND 5 SYNONYM: LEUKOCYTE ADHESION GLYCOPROTEIN LFA-1 ALPHA CHAIN, LFA-1A, COMPND 6 LEUKOCYTE FUNCTION-ASSOCIATED MOLECULE 1 ALPHA CHAIN, CD11A ANTIGEN; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ITGAL, CD11A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A; SOURCE 11 OTHER_DETAILS: MINIMAL MEDIA KEYWDS INHIBITOR, PROTEIN-LIGAND COMPLEX, CELL ADHESION EXPDTA X-RAY DIFFRACTION AUTHOR S.SHERIFF REVDAT 4 30-AUG-23 2O7N 1 REMARK SEQADV REVDAT 3 18-OCT-17 2O7N 1 REMARK REVDAT 2 24-FEB-09 2O7N 1 VERSN REVDAT 1 20-MAR-07 2O7N 0 JRNL AUTH D.S.DODD,S.SHERIFF,C.J.CHANG,D.K.STETSKO,L.M.PHILLIPS, JRNL AUTH 2 Y.ZHANG,M.LAUNAY,D.POTIN,W.VACCARO,M.A.POSS,M.MCKINNON, JRNL AUTH 3 J.C.BARRISH,S.J.SUCHARD,T.G.MURALI DHAR JRNL TITL DESIGN OF LFA-1 ANTAGONISTS BASED ON A JRNL TITL 2 2,3-DIHYDRO-1H-PYRROLIZIN-5(7AH)-ONE SCAFFOLD. JRNL REF BIOORG.MED.CHEM.LETT. V. 17 1908 2007 JRNL REFN ISSN 0960-894X JRNL PMID 17291752 JRNL DOI 10.1016/J.BMCL.2007.01.036 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.POTIN,M.LAUNAY,F.MONATLIK,P.MALABRE,M.FABREGUETTES, REMARK 1 AUTH 2 A.FOUQUET,M.MAILLET,E.NICOLAI,L.DORGERET,F.CHEVALLIER, REMARK 1 AUTH 3 D.BESSE,M.DUFORT,F.CAUSSADE,S.Z.AHMAD,D.K.STETSKO,S.SKALA, REMARK 1 AUTH 4 P.M.DAVIS,P.BALIMANE,K.PATEL,Z.YANG,P.MARATHE,J.POSTELNECK, REMARK 1 AUTH 5 R.M.TOWNSEND,V.GOLDFARB,S.SHERIFF,H.EINSPAHR,K.KISH, REMARK 1 AUTH 6 M.F.MALLEY,J.D.DIMARCO,J.Z.GOUGOUTAS,P.KADIYALA,D.L.CHENEY, REMARK 1 AUTH 7 R.W.TEJWANI,D.K.MURPHY,K.W.MCINTYRE,X.YANG,S.CHAO,L.LEITH, REMARK 1 AUTH 8 Z.XIAO,A.MATHUR,B.C.CHEN,D.R.WU,S.C.TRAEGER,M.MCKINNON, REMARK 1 AUTH 9 J.C.BARRISH,J.A.ROBL,E.J.IWANOWICZ,S.J.SUCHARD,T.G.DHAR REMARK 1 TITL DISCOVERY AND DEVELOPMENT OF 5-[(5S,9R)-9- REMARK 1 TITL 2 (4-CYANOPHENYL)-3-(3,5-DICHLOROPHENYL)-1- REMARK 1 TITL 3 METHYL-2,4-DIOXO-1,3,7-TRIAZASPIRO[4.4]NON- REMARK 1 TITL 4 7-YL-METHYL]-3-THIOPHENECARBOXYLIC ACID (BMS-587101)--A REMARK 1 TITL 5 SMALL MOLECULE ANTAGONIST LEUKOCYTE FUNCTION ASSOCIATED REMARK 1 TITL 6 ANTIGEN-1. REMARK 1 REF J.MED.CHEM. V. 49 6946 2006 REMARK 1 REFN ISSN 0022-2623 REMARK 1 PMID 17125246 REMARK 1 DOI 10.1021/JM0610806 REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.55 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1680683.350 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 21758 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.215 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.000 REMARK 3 FREE R VALUE TEST SET COUNT : 643 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.010 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2150 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2150 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 3.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 643 REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : 0.0090 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 21758 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.83 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2542 REMARK 3 BIN R VALUE (WORKING SET) : 0.2610 REMARK 3 BIN FREE R VALUE : 0.2790 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 2.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 74 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.032 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1455 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 122 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.41000 REMARK 3 B22 (A**2) : -3.05000 REMARK 3 B33 (A**2) : 4.46000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : 0.12 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.16 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.810 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.160 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.730 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.140 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.200 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : BABINET REMARK 3 KSOL : 1.00 REMARK 3 BSOL : 280.0 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : 2O7.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : 2O7.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2O7N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-DEC-06. REMARK 100 THE DEPOSITION ID IS D_1000040789. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-NOV-03 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.90 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 32-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21828 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 7.100 REMARK 200 R MERGE (I) : 0.09200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.1 REMARK 200 DATA REDUNDANCY IN SHELL : 7.00 REMARK 200 R MERGE FOR SHELL (I) : 0.30600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1LFA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 78% (W/V) SODIUM CITRATE, 3% (V/V) REMARK 280 ETHYLENE GLYCOL, 0.1 M SODIUM CITRATE, PH 5.6 (FINAL PH 8.9), REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K, PH 8.90 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 35.55000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 35.55000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 33.80000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 44.20000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 33.80000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 44.20000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 35.55000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 33.80000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 44.20000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 35.55000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 33.80000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 44.20000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 348 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 125 REMARK 465 SER A 126 REMARK 465 HIS A 127 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ASP A 145 CG OD1 OD2 REMARK 480 ASN A 163 CG OD1 ND2 REMARK 480 ARG A 189 CG CD NE CZ NH1 NH2 REMARK 480 LYS A 190 CE NZ REMARK 480 LYS A 197 CE NZ REMARK 480 LYS A 200 NZ REMARK 480 ARG A 221 CZ NH1 NH2 REMARK 480 GLU A 241 CG CD OE1 OE2 REMARK 480 LYS A 263 CG CD CE NZ REMARK 480 HIS A 264 CG ND1 CD2 CE1 NE2 REMARK 480 LYS A 268 CD CE NZ REMARK 480 GLU A 269 CD OE1 OE2 REMARK 480 LYS A 296 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 163 40.26 -93.25 REMARK 500 SER A 174 -109.19 -149.83 REMARK 500 ARG A 189 -0.65 -142.36 REMARK 500 LEU A 204 -132.42 -122.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2O7 A 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2ICA RELATED DB: PDB DBREF 2O7N A 129 307 UNP P20701 ITAL_HUMAN 154 332 SEQADV 2O7N GLY A 125 UNP P20701 CLONING ARTIFACT SEQADV 2O7N SER A 126 UNP P20701 CLONING ARTIFACT SEQADV 2O7N HIS A 127 UNP P20701 CLONING ARTIFACT SEQADV 2O7N MET A 128 UNP P20701 CLONING ARTIFACT SEQRES 1 A 183 GLY SER HIS MET ASN VAL ASP LEU VAL PHE LEU PHE ASP SEQRES 2 A 183 GLY SER MET SER LEU GLN PRO ASP GLU PHE GLN LYS ILE SEQRES 3 A 183 LEU ASP PHE MET LYS ASP VAL MET LYS LYS LEU SER ASN SEQRES 4 A 183 THR SER TYR GLN PHE ALA ALA VAL GLN PHE SER THR SER SEQRES 5 A 183 TYR LYS THR GLU PHE ASP PHE SER ASP TYR VAL LYS ARG SEQRES 6 A 183 LYS ASP PRO ASP ALA LEU LEU LYS HIS VAL LYS HIS MET SEQRES 7 A 183 LEU LEU LEU THR ASN THR PHE GLY ALA ILE ASN TYR VAL SEQRES 8 A 183 ALA THR GLU VAL PHE ARG GLU GLU LEU GLY ALA ARG PRO SEQRES 9 A 183 ASP ALA THR LYS VAL LEU ILE ILE ILE THR ASP GLY GLU SEQRES 10 A 183 ALA THR ASP SER GLY ASN ILE ASP ALA ALA LYS ASP ILE SEQRES 11 A 183 ILE ARG TYR ILE ILE GLY ILE GLY LYS HIS PHE GLN THR SEQRES 12 A 183 LYS GLU SER GLN GLU THR LEU HIS LYS PHE ALA SER LYS SEQRES 13 A 183 PRO ALA SER GLU PHE VAL LYS ILE LEU ASP THR PHE GLU SEQRES 14 A 183 LYS LEU LYS ASP LEU PHE THR GLU LEU GLN LYS LYS ILE SEQRES 15 A 183 TYR HET 2O7 A 1 28 HETNAM 2O7 7A-[(4-CYANOPHENYL)METHYL]-6-(3,5-DICHLOROPHENYL)-5- HETNAM 2 2O7 OXO-2,3,5,7A-TETRAHYDRO-1H-PYRROLO[1,2-A]PYRROLE-7- HETNAM 3 2O7 CARBONITRILE HETSYN 2O7 (7AS)-7A-(4-CYANOBENZYL)-6-(3,5-DICHLOROPHENYL)-5-OXO- HETSYN 2 2O7 2,3,5,7A-TETRAHYDRO-1H-PYRROLIZINE-7-CARBONITRILE FORMUL 2 2O7 C22 H15 CL2 N3 O FORMUL 3 HOH *122(H2 O) HELIX 1 1 GLN A 143 LEU A 161 1 19 HELIX 2 2 ASP A 182 LYS A 190 1 9 HELIX 3 3 ASP A 191 LEU A 196 1 6 HELIX 4 4 ASN A 207 VAL A 219 1 13 HELIX 5 5 ARG A 221 GLY A 225 5 5 HELIX 6 6 ILE A 248 LYS A 252 5 5 HELIX 7 7 LYS A 263 GLN A 266 5 4 HELIX 8 8 THR A 267 THR A 273 1 7 HELIX 9 9 LEU A 274 ALA A 278 5 5 HELIX 10 10 PRO A 281 PHE A 285 1 5 HELIX 11 11 GLU A 293 LYS A 304 1 12 SHEET 1 A 6 TYR A 177 PHE A 181 0 SHEET 2 A 6 GLN A 167 PHE A 173 -1 N GLN A 172 O LYS A 178 SHEET 3 A 6 VAL A 130 ASP A 137 1 N PHE A 134 O VAL A 171 SHEET 4 A 6 THR A 231 THR A 238 1 O ILE A 235 N LEU A 135 SHEET 5 A 6 ILE A 255 ILE A 261 1 O ILE A 259 N ILE A 236 SHEET 6 A 6 VAL A 286 LEU A 289 1 O LYS A 287 N ILE A 258 CISPEP 1 LYS A 280 PRO A 281 0 0.17 SITE 1 AC1 9 LEU A 132 TYR A 166 LEU A 203 ILE A 235 SITE 2 AC1 9 TYR A 257 LEU A 302 LYS A 305 ILE A 306 SITE 3 AC1 9 HOH A 313 CRYST1 67.600 88.400 71.100 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014793 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011312 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014065 0.00000